Skip to content
A concentration of scientific expertise, extensive manufacturing activity, and state support have helped make biotech one of the fastest-growing areas of employment in Illinois. […]
BIO on the American Road: Biotech innovation and job growth in Illinois Read More »
Not many people know what amyloidosis is, and for Mike Lane, Founder of the Amyloidosis Army, that’s a problem he wants to change. “That’s
Amyloidosis: Under-diagnosed disorder with serious consequences Read More »
European countries don’t just pull prices for medicines out of thin air. The prices that those governments set are based on specific sets of
The rapidly growing biotech ecosystem supporting innovation in Texas received national attention during a visit by the Biotechnology Innovation Organization (BIO) on Sept. 15-16.
BIO on the American Road: Everything’s big in Texas, including biotech Read More »
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is
Putting Americans First: International prices in context Read More »
Already providing employment for 129,245 people and $95 billion in annual economic output, Texas’s biotech sector is growing rapidly. That sector will be highlighted
BIO’s Texas visit will highlight a growing biotech ecosystem Read More »
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the
It has been three years since the Inflation Reduction Act (IRA) was signed into law. “We have definitively seen negative impacts on patient access,
BIO Coffee Chat looks at patient access after three years of the IRA Read More »
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner of the 2025 BIO Start-Up Stadium seed-stage category. For founder and
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable Read More »
A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in
Startup Stadium: Tezcat Biosciences targets common cancer mutation Read More »
